Sophia Analysis by Chemotherapy (Ctx) Choice: A Phase Iii (P3) Study of Margetuximab (M) plus Ctx Versus Trastuzumab (T) plus Ctx in Patients (Pts) with Pretreated Her2+Metastatic (Met) Breast Cancer (Mbc).
AuthID
P-00S-VCD
P-00S-VCD